Quinn Opportunity Partners’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
6CM
KGAMU
WPM
RC
Quinn Opportunity Partners's CDLX Position: Q2 2026 in Review
Quinn Opportunity Partners reduced its Cardlytics (CDLX) stake by 0% in Q2 2026, selling an estimated $7 and leaving 46,239 shares worth $208K. The position accounts for 0.01% of the portfolio, ranked #326.
Quinn Opportunity Partners first reported a position in CDLX in Q3 2020 and has held it in 11 quarters since. The position peaked at $2.67M in Q3 2025. 42 funds tracked by Wall St. Rank hold CDLX as of Q2 2026.
- Quinn Opportunity Partners held 46,239 shares of Cardlytics worth $208K as of Q2 2026.
- Quinn Opportunity Partners sold 1 Cardlytics share in Q2 2026, an estimated $7.
- Cardlytics made up 0.01% of Quinn Opportunity Partners's portfolio in Q2 2026, its #326 holding.
- Quinn Opportunity Partners first reported a position in Cardlytics in Q3 2020 and has held it in 11 quarters since.
- Quinn Opportunity Partners's Cardlytics position peaked at $2.67M in Q3 2025.
- 42 funds tracked by Wall St. Rank held Cardlytics as of Q2 2026.
Based on Quinn Opportunity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.